|

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

RECRUITINGSponsored by Kang Stem Biotech Co., Ltd.
Actively Recruiting
SponsorKang Stem Biotech Co., Ltd.
Started2019-10-02
Est. completion2025-08-11
Eligibility
Age19 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04134169

Summary

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

Eligibility

Age: 19 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Subject who enrolled K0202 Clinical Trial(parent study) and has been given more than one medication.
2. Subjects who understand and voluntarily sign an informed consent form

Exclusion Criteria:

1\. Any other condition which the investigator judges would make patient unsuitable for study participation

Conditions2

ArthritisRheumatoid Arthritis

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.